Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,199.0
25.2 (0.79%)

 

  • STI Straits Times Index
    3,199.0
    25.2 (0.79%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,606.0
    7.7 (0.48%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    25,787.2
    377.5 (1.49%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,593.2
    25.0 (0.70%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    29,215.5
    190.1 (0.65%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,656.0
    -2.8 (-0.04%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,613.6M
  • Value: 1,230.2M
  • Rise: 192
  • Fall: 154
  • Unch: 405

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Sembcorp Marine0.081-0.001
Hatten Land0.073-0.005
Jiutian Chemical0.089-0.002
Shen Yao0.003-0.001
Rex Intl0.350+0.025
AusGroup0.029+0.003
Singtel2.550-
Sinjia Land0.052+0.005
Oceanus0.040-
Leader Env0.083+0.009

World Indices

World Indices
Name Last Change
Nasdaq 15,021.8 +124.5
HSI 25,787.2 +377.5
HSCEI 9,136.1 +164.7
Jakarta 6,656.0 -2.8
Nikkei 225 29,215.5 +190.1
SSE Comp 3,593.2 +25.0
Shanghai A 3,765.7 +26.2
Shanghai B 280.0 +0.7
KOSPI 3,029.0 +22.4

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

GRAYBUG VISION INC GRAYBUG VISION
Updated on 18 Oct 2021 (End of trading day)
Last (USD): 3.560 Change: +0.020 High: 3.600 Remarks: -
Change (%): +0.56 Low: 3.350
Open 3.540 Yesterday's Close 3.54
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 220,119 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -1.63122 Trailing EPS (USD) e -1.66415 NAV (USD) b 3.6959
PE a - Trailing PE f - Price / NAV b 0.9632
Dividend (USD) d - Cash In Hand (USD) g 0.3695 Issued & Paid-up Shares c 21,284,700
Dividend Yield (%) d - Price / Cash In Hand g 9.635 Treasury Shares h -
Market Cap (M) 75.774 Enterprise Value (M) 2.188
Piotroski F Score 2 Exchange Code GRAY Par Value ( $ ) n.a.
52 Weeks Volatility (%) 122.41 Free Float (%) 67.9
Sector & Industry Health Technology - Pharmaceuticals: Major
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. The figure pertains to the respective exchange the stock is listed on. Updated on 17 Aug 2021.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 23 Sep 2020.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference GRAYBUG VISION INC NASDAQ 75.774 - - 0.9632 -
Industry Pharmaceuticals: Major NASDAQ 2,303.229 87.401 91.614 3.3401 1.400
Local Peer ASTRAZENECA SPON ADR EACH REP 0.50 ORD SHS NASDAQ 183,696.428 57.477 48.713 11.7183 1.958
Local Peer SANOFI SPON ADR ECH REP 0.5 ORD SHS NASDAQ 121,368.928 8.646 17.526 1.6184 2.784
Local Peer ROYALTY PHARMA PLC NASDAQ 22,477.507 23.053 23.136 3.9202 0.518
Local Peer VIATRIS INC NASDAQ 16,313.322 - - 0.7692 -
Local Peer REPLIGEN CORP NASDAQ 14,501.886 241.996 145.116 9.0463 -
Local Peer ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS NASDAQ 8,818.164 - - 10.8160 -
Local Peer LEGEND BIOTECH CORP SPON ADS EACH REP 2 ORD SHS NASDAQ 7,454.218 - - 21.9294 -
Local Peer CUREVAC NV NASDAQ 7,631.296 - - - -
Local Peer ALLAKOS INC NASDAQ 5,617.796 - - 9.8388 -
Local Peer HUTCHMED (CHINA) LIMITED SPON ADS EACH REPR 5 ORD SHS NASDAQ 5,587.579 - - 5.6739 -
Local Peer CEREVEL THERAPEUTICS HLDGS INC NASDAQ 5,244.294 - - 17.8448 -
Local Peer I MAB SPON ADS EACH REP 2.3 ORD SHS NASDAQ 5,174.196 75.838 75.839 6.0134 -
Other Local Peers GRIFOLS SA SPON ADR EA REPR 1 ORD EUR0.10 (NASDAQ), KARUNA THERAPEUTICS INC (NASDAQ), IMMUNITYBIO INC (NASDAQ), REATA PHARMACEUTICALS INC (NASDAQ), ATEA PHARMACEUTICALS INC (NASDAQ), NEKTAR THERAPEUTICS (NASDAQ), APELLIS PHARMACEUTICALS INC (NASDAQ), SPRINGWORKS THERAPEUTICS INC (NASDAQ), OPKO HEALTH INC (NASDAQ), TURNING POINT THERAPEUTICS INC (NASDAQ), HARMONY BIOSCIENCES HLDGS INC (NASDAQ), ERASCA INC (NASDAQ), ATAI LIFE SCIENCES NV (NASDAQ), IGM BIOSCIENCES INC (NASDAQ), QUANTERIX CORPORATION (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), CENTESSA PHARMACEUTICALS PLC SPON ADS EACH REPR 1 ORD SHS (NASDAQ), DAY ONE BIOPHARMACEUTICALS INC (NASDAQ), ZEALAND PHARMA AS SPON ADR EACH REP 1 ORD SHS (NASDAQ), NURIX THERAPEUTICS INC (NASDAQ), GENERATION BIO CO (NASDAQ), OLEMA PHARMACEUTICALS INC (NASDAQ), ARCTURUS THERAPEUTICS HOLDINGS INC (NASDAQ), Y-MABS THERAPEUTICS INC (NASDAQ), ARCUTIS BIOTHERAPEUTICS INC (NASDAQ), PROCAPS GROUP S A (NASDAQ), CULLINAN ONCOLOGY INC (NASDAQ), GOSSAMER BIO INC (NASDAQ), FULCRUM THERAPEUTICS INC (NASDAQ), PHATHOM PHARMACEUTICALS INC (NASDAQ), KINNATE BIOPHARMA INC (NASDAQ), ICOSAVAX INC (NASDAQ), CONNECT BIOPHARMA HLDGS LTD ADS EACH REP ONE ORD SHARE (NASDAQ), KRONOS BIO INC (NASDAQ), KEROS THERAPEUTICS INC (NASDAQ), PRAXIS PRECISION MEDICINES INC (NASDAQ), IDEAYA BIOSCIENCES INC (NASDAQ), PHIBRO ANIMAL HEALTH CORP (NASDAQ), SUTRO BIOPHARMA INC (NASDAQ), FORMA THERAPEUTICS HLDGS INC (NASDAQ), OCULAR THERAPEUTIX INC (NASDAQ), TENAYA THERAPEUTICS INC (NASDAQ), ANNEXON INC (NASDAQ), GH RESEARCH PLC (NASDAQ), REPARE THERAPEUTICS INC (NASDAQ), MIND MEDICINE (MINDMED) INC (NASDAQ), KINIKSA PHARMACEUTICALS LTD (NASDAQ), CRINETICS PHARMACEUTICALS INC (NASDAQ), AMRYT PHARMA PLC (NEW) SPON ADS EACH REP 5 ORD SHS (NASDAQ), PETIQ INC (NASDAQ), AKERO THERAPEUTICS INC (NASDAQ), POINT BIOPHARMA GLOBAL INC (NASDAQ), VERU INC (NASDAQ), ALIGOS THERAPEUTICS INC (NASDAQ), BEYONDSPRING INC (NASDAQ), ALPHA TEKNOVA INC (NASDAQ), TALARIS THERAPEUTICS INC (NASDAQ), ORIC PHARMACEUTICALS INC (NASDAQ), TARSUS PHARMACEUTICALS INC (NASDAQ), CALLIDITAS THERAPEUTICS AB SPON ADS EACH REP 2 ORD SHS (NASDAQ), NRX PHARMACEUTICALS INC (NASDAQ), ACUMEN PHARMACEUTICALS INC (NASDAQ), SPERO THERAPEUTICS INC (NASDAQ), CHINOOK THERAPEUTICS INC (NASDAQ), G1 THERAPEUTICS IN (NASDAQ), SIGA TECHNOLOGIES INC (NASDAQ), PHARVARIS NV (NASDAQ), MIRUM PHARMACEUTICALS INC (NASDAQ), ADAGENE INC SPON ADS EACH REP 1.25 ORD SHS (NASDAQ), VACCITECH PLC ADR EACH REPR 1 ORD SH SPON (NASDAQ), BOLT BIOTHERAPEUTICS INC (NASDAQ), WEREWOLF THERAPEUTICS INC (NASDAQ), GRITSTONE BIO INC (NASDAQ), AC IMMUNE SA (NASDAQ), APPLIED THERAPEUTICS INC (NASDAQ), NANOBIOTIX S A SPON ADS EACH REP 1 ORD SHS (NASDAQ), EVELO BIOSCIENCES INC (NASDAQ), KALVISTA PHARMACEUTICALS INC (NASDAQ), EVOLUS INC (NASDAQ), RELMADA THERAPEUTICS INC (NASDAQ), MINK THERAPEUTICS INC (NASDAQ), PROVENTION BIO INC (NASDAQ), PYXIS ONCOLOGY INC (NASDAQ), CLENE INC (NASDAQ), VERRICA PHARMACEUTICALS INC (NASDAQ), 89BIO INC (NASDAQ), ESSA PHARMA INC (NASDAQ), OYSTER POINT PHARMA INC (NASDAQ), PDS BIOTECHNOLOGY CORPORATION (NASDAQ), SILVERBACK THERAPEUTICS INC (NASDAQ), BIOMEA FUSION INC (NASDAQ), CLEARSIDE BIOMEDICAL INC (NASDAQ), THERATECHNOLOGIES INC (NASDAQ), CODIAK BIOSCIENCES INC (NASDAQ), EYEPOINT PHARMACEUTICALS INC (NASDAQ), FUSION PHARMACEUTICALS INC (NASDAQ), TCR2 THERAPEUTICS INC (NASDAQ), ACHILLES THERAPEUTICS PLC ADS EACH REPR 1 SHARE SPON (NASDAQ), CITIUS PHARMACEUTICALS INC (NASDAQ), ATHENEX INC (NASDAQ), XOMA CORP (NASDAQ), NEXIMMUNE INC (NASDAQ), CHECKPOINT THERAPEUTICS INC (NASDAQ), DURECT CORP (NASDAQ), ORCHARD THERAPEUTICS PLC SPON ADS EACH REPR 1 ORD SHS (NASDAQ), HARROW HEALTH INC (NASDAQ), VINCERX PHARMA INC (NASDAQ), ANGION BIOMEDICA CORP (NASDAQ), OVID THERAPEUTICS INC (NASDAQ), REGENCELL BIOSCIENCE HLDGS LTD (NASDAQ), TRICIDA INC (NASDAQ), GAMIDA CELL LTD (NASDAQ), OBSEVA SA (NASDAQ), REDHILL BIOPHARMA LTD SPON ADS EA REPR 10 ORD ILS0.00 (NASDAQ), IMMUNIC INC (NASDAQ), IMPEL NEUROPHARMA INC (NASDAQ), VECTIVBIO HLDG AG (NASDAQ), INOZYME PHARMA INC (NASDAQ), SOL GEL TECHNOLOGIES LTD (NASDAQ), KALEIDO BIOSCIENCES INC (NASDAQ), CORVUS PHARMACEUTICALS INC (NASDAQ), MUSTANG BIO INC (NASDAQ), ALZAMEND NEURO INC (NASDAQ), TFF PHARMACEUTICALS INC (NASDAQ), GALERA THERAPEUTICS INC (NASDAQ), PHASEBIO PHARMACEUTICALS INC (NASDAQ), ONCTERNAL THERAPEUTICS INC (NASDAQ), 180 LIFE SCIENCES CORP (NASDAQ), SCPHARMACEUTICALS INC (NASDAQ), MILESTONE PHARMACEUTICALS INC (NASDAQ), TYME TECHNOLOGIES INC (NASDAQ), 4D PHARMA PLC SPONS ADR EACH REP 8 ORD SHS (NASDAQ), ADAMIS PHARMACEUTICALS CORPORATION (NASDAQ), ANEBULO PHARMACEUTICALS INC (NASDAQ), LIQUIDIA CORPORATION (NASDAQ), HOOKIPA PHARMA INC (NASDAQ), RENEO PHARMACEUTICALS INC (NASDAQ), SATSUMA PHARMACEUTICALS INC (NASDAQ), AQUESTIVE THERAPEUTICS INC (NASDAQ), OSMOTICA PHARMACEUTICALS PLC (NASDAQ), ORPHAZYME A/S SPON ADS REP 1 ORD SHS (NASDAQ), KALA PHARMACEUTICALS INC (NASDAQ), NOVAN INC (NASDAQ), QILIAN INTERNATIONAL HLDG GROUP LTD (NASDAQ), POLYPID LTD (NASDAQ), F-STAR THERAPEUTICS INC (NASDAQ), EYENOVIA INC (NASDAQ), AYALA PHARMACEUTICALS INC (NASDAQ), ENTERA BIO LTD (NASDAQ), LOGICBIO THERAPEUTICS INC (NASDAQ), NEUBASE THERAPEUTICS INC (NASDAQ), ETON PHARMACEUTICALS INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), CLARUS THERAPEUTICS HLDGS INC (NASDAQ), CYCLERION THERAPEUTICS INC (NASDAQ), ODONATE THERAPEUTICS INC (NASDAQ), GENPREX INC (NASDAQ), LANTERN PHARMA INC (NASDAQ), DARE BIOSCIENCE INC (NASDAQ), APREA THERAPEUTICS INC (NASDAQ), EDESA BIOTECH INC (NASDAQ), LYRA THERAPEUTICS INC (NASDAQ), TEMPEST THERAPEUTICS INC (NASDAQ), IMARA INC (NASDAQ), MEDIWOUND LTD (NASDAQ), APTORUM GROUP LIMITED (NASDAQ), AILERON THERAPEUTICS INC (NASDAQ), YUMANITY THERAPEUTICS INC (NASDAQ), GALECTO INC (NASDAQ), PROPHASE LABS INC (NASDAQ), ELEDON PHARMACEUTICALS INC (NASDAQ), PURPLE BIOTECH LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), ADIAL PHARMACEUTICALS INC (NASDAQ), AKARI THERAPEUTICS PLC SPON ADR EACH REPR 100 ORD (NASDAQ), MOLECULIN BIOTECH INC (NASDAQ), PROTARA THERAPEUTICS INC (NASDAQ), AYTU BIOPHARMA INC (NASDAQ), OCUPHIRE PHARMA INC (NASDAQ), ALLENA PHARMACEUTICALS INC (NASDAQ), SYNAPTOGENIX INC (NASDAQ), ADDEX THERAPEUTICS LIMITED SPON ADS EACH REP 6 ORD SHS (NASDAQ), MANNATECH INC (NASDAQ), ABVC BIOPHARMA INC (NASDAQ), BONE BIOLOGICS CORP (NASDAQ), VYNE THERAPEUTICS INC (NASDAQ), VIRPAX PHARMA INC (NASDAQ), UNIVERSE PHARMACEUTICALS INC (NASDAQ), REVIVA PHARMACEUTICALS HOLDINGS INC (NASDAQ), RENOVORX INC (NASDAQ), ACURX PHARMACEUTICALS INC (NASDAQ), BRICKELL BIOTECH INC (NASDAQ), INHIBIKASE THERAPEUTICS INC (NASDAQ), BAUDAX BIO INC (NASDAQ), VALLON PHARMACEUTICALS INC (NASDAQ), ASSERTIO HOLDINGS INC (NASDAQ), ARIDIS PHARMACEUTICAL INC (NASDAQ), SEQLL INC (NASDAQ), CNS PHARMACEUTICALS INC (NASDAQ), VIRIOS THERAPEUTICS INC (NASDAQ), PASITHEA THERAPEUTICS CORP (NASDAQ), XORTX THERAPEUTICS INC (NASDAQ), DERMATA THERAPEUTICS INC (NASDAQ), ACER THERAPEUTICS INC (NASDAQ), BIONDVAX PHARMACEUTICALS SPON ADS REP 40 ORD SHS (NASDAQ), NLS PHARMACEUTICS LTD (NASDAQ), TREVI THERAPEUTICS INC (NASDAQ), HOTH THERAPEUTICS INC (NASDAQ), PAINREFORM LTD (NASDAQ), PANBELA THERAPEUTICS INC (NASDAQ), AVENUE THERAPEUTICS INC (NASDAQ), IMMURON LIMITED SPON ADR EACH REPR 40 ORD SHS (NASDAQ), TITAN PHARMACEUTICAL INC (NASDAQ), PETROS PHARMACEUTICALS INC (NASDAQ), TELIGENT INC NEW (NASDAQ), CHINA SXT PHARMACEUTICALS INC (NASDAQ)
Global Peer JOHNSON & JOHNSON NYSE 421,512.698 28.647 23.724 6.0580 2.486
Global Peer PFIZER INC NYSE 231,668.431 24.092 17.513 3.3076 3.677
Global Peer ELI LILLY AND COMPANY NYSE 228,603.727 36.909 37.657 35.4733 1.239
Global Peer NOVARTIS AG ADR-EACH REPR 1 CHF0.5(REGD) NYSE 200,450.143 24.685 22.287 3.7092 2.341
Global Peer MERCK & CO INC NYSE 195,295.196 27.635 35.056 5.8658 3.213
Global Peer ABBVIE INC NYSE 189,848.147 41.670 28.813 15.1044 4.500
Global Peer NOVO NORDISK A/S ADR-EACH CNV INTO 1 CLASS B DKK1 NYSE 183,335.881 28.451 25.753 17.5356 1.301
Global Peer BRISTOL-MYERS SQUIBB CO NYSE 126,526.943 - - 3.4375 3.263
Global Peer GLAXOSMITHKLINE ADR EACH CNV INTO 2 ORD GBP0.25 NYSE 97,238.375 13.190 16.394 4.5775 5.353
Global Peer WUXI APPTEC CO LTD HKEx 509,180.222 153.412 109.951 11.5335 0.204
Other Global Peers TAKEDA PHARMACEUTICAL CO LTD SPON ADS EACH REP 0.5 ORD SHS (NYSE), HANSOH PHARMACEUTICAL GROUP CO LTD (HKEx), INNOVENT BIOLOGICS INC (HKEx), CANSINO BIOLOGICS INC (HKEx), ORGANON & CO (NYSE), BIOHAVEN PHARMACEUTICAL HLDG CO LTD (NYSE), SINOPHARM GROUP CO. LTD. (HKEx), REMEGEN CO LTD (HKEx), SHANGHAI PHARMACEUTICALS HOLDING CO (HKEx), HUTCHMED (CHINA) LIMITED (HKEx), HYGEIA HEALTHCARE HLDGS CO LTD (HKEx), SHANGHAI JUNSHI BIOSCIENCES CO LTD (HKEx), AKESO INC (HKEx), CHINA MEDICAL SYSTEM HLDGS LTD (HKEx), GUANGZHOU BAIYUNSHAN PHARMACEUTICAL (HKEx), INNOCARE PHARMA LTD (HKEx), CHINA RESOURCES PHARMACEUTICAL GR (HKEx), CHINA GRAND PHARMACEUTICAL & HEALTH (HKEx), CARSGEN THERAPEUTICS HLDGS LTD (HKEx), EMERGENT BIOSOLUTIONS INC (NYSE), SIMCERE PHARMACEUTICAL GRP LTD (HKEx), CHINA TRADITIONAL CHINESE MED HLDGS (HKEx), ADC THERAPEUTICS SA (NYSE), SHANGHAI HENLIUS BIOTECH INC (HKEx), AMNEAL PHARMACEUTICALS INC (NYSE), EVEREST MEDICINES LTD (HKEx), SHENZHEN HEPALINK PHARMACEUTICAL (HKEx), SSY GROUP LIMITED (HKEx), CSTONE PHARMACEUTICALS (HKEx), OCUMENSION THERAPEUTICS (HKEx), UNITED LABORATORIES INTL HLDGS LTD (HKEx), ZYMEWORKS INC (NYSE), Kimia Farma Tbk. (IDX), ABBISKO CAYMAN LTD (HKEx), BEIJING TONG REN TANG CHINESE MEDIC (HKEx), BROOKLYN IMMUNO THERAPEUTICS INC (NYSE American), IMMUNOTECH BIOPHARM LTD (HKEx), CK LIFE SCIENCES INTL HLDG (HKEx), SCICLONE PHARMACEUTICALS (HLDGS) LT (HKEx), ANTENGENE CORP LTD (HKEx), TRANSCENTA HOLDING LTD (HKEx), CHINA SHINEWAY PHARMACEUTICAL GR (HKEx), HUA MEDICINE (HKEx), ZHAOKE OPHTHALMOLOGY LTD (HKEx), Soho Global Health Tbk. (IDX), IGBB (Bursa), STARPHARMA HOLDINGS LIMITED (ASX), RACE ONCOLOGY LTD (ASX), PYC THERAPEUTICS LIMITED (ASX), TOT BIOPHARM INTL CO LTD (HKEx), DAWNRAYS PHARMACEUTICAL HLDGS (HKEx), CYBIN INC (NYSE American), AFT PHARMACEUTICALS LTD (ASX), NAVIDEA BIOPHARMACEUTICALS INC (NYSE American), BSTEAD (Bursa), FUSEN PHARMACEUTICAL CO LTD (HKEx), PHARMA (Bursa), ANNOVIS BIO INC (NYSE American), IP (SET), CHINA BIOTECH SERVICES HLDGS LTD (HKEx), IX Biopharma (SGX), ZHONGZHI PHARMACEUTICAL HLDGS LTD (HKEx), RECCE PHARMACEUTICALS LTD (ASX), Merck Tbk. (IDX), NOXOPHARM LTD (ASX), LANNETT CO INC (NYSE), KOTRA (Bursa), CRESO PHARMA LTD (ASX), CHARMACY PHARMACEUTICAL CO LTD (HKEx), NEW RAY MEDICINE INTL HLDG LTD (HKEx), Phapros Tbk. (IDX), NEW CENTURY HEALTHCAR